1. P. W. Dykes, A. R. Bradwell, C. E. Chapman, and A. T. M. Vaughan. Radioimmunotherapy of cancer: Clinical studies and limiting factors.Cancer Treat. Rev. 14:87–106 (1987).
2. A. A. Epenetos, D. Snook, H. Durbin, P. M. Johnson, and J. J. Taylor-Papadimitriou. Limitations of radiolabelled monoclonal antibodies for localisation of human neoplasms.Cancer Res. 46:3183–3191 (1986).
3. C. H. J. Ford and A. G. Casson. Antibody-mediated targeting in the treatment and diagnosis of cancer: An overview.Cancer Chemother. Pharmacol. 17:197–208 (1986).
4. A. A. Epenetos, C. C. Nimmon, J. Arklie, A. T. Elliott, L. A. Hawkins, R. W. Knowles, K. E. Britton, and W. F. Bodmer. Detection of human cancer in an animal model using radiolabelled tumour-associated monoclonal antibodies.Br. J. Cancer 46:1–8 (1982).
5. A. M. Keenan, D. Colcher, S. M. Larson, and J. Scholm. Radioimmunoscintigraphy of human colon cancer xenografts in mice with radioiodonated monoclonal antibody B72.3.J. Nucl. Med. 25:1197–1203 (1984).